Sentences with phrase «unmet medical»

Our mission is to accelerate stem cell treatments for patients with unmet medical needs by funding promising stem cell research in California.
These should include the cost of a funeral — including burial and headstone expenses — as well as any unmet medical costs, estate taxes, and possible costs of probate.
Investing $ 300 million annually in research and development — more than any other animal health company — which have led to new therapies that address unmet medical needs.
The company also plan to continue to evaluate other opportunities for potential product candidates for the treatment of unmet medical needs.
It is focused on the development of preventive and therapeutic vaccine products and cancer drugs for patients with unmet medical needs.
NTII is a biopharmaceutical company historically focused on developing treatments for central nervous system conditions and other serious unmet medical needs.
Horizon Pharma Plc is a specialty biopharmaceutical company, which engages in the business of identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs.
«Nutrition is likely one of the most powerful medicines and interventions to complement cancer therapy with impact on cancer metabolism and immune biology — at last a program with a well - balanced educational curriculum that addresses this important area of unmet medical need»
For example, Novartis and the University of Pennsylvania's lead candidate (CTL019) for treating a range of hematological malignancies received breakthrough status from the US Food and Drug Administration (FDA) in 2014, permitting access to an expedited drug development pathway for high unmet medical needs.
Pieris president and chief executive officer, Stephen Yoder, said that Anticalins show promise in addressing high - unmet medical needs and expanding the potential of targeted therapeutics.
Our talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.
Focused on meeting this urgent unmet medical need, ALS TDI executes a robust target discovery program, while simultaneously operating the world's largest efforts to preclinically validate potential therapeutics; including a pipeline of dozens of small molecules, protein biologics, gene therapies and cell - based constructs.
Advances in cell therapy have resulted in significant progress toward treating some widespread and difficult diseases, many of which represent unmet medical needs.
Clinical Applications and Bioprocessing Strategies Fundamentally, gene therapy should exceed the efficacy of existing therapeutic approaches and provide therapeutic strategies for unmet medical needs.
The variety of very different molecular architectures that these researchers have engineered to meet similar purposes illustrates the richness of the toolkit that nanotechnology is providing to satisfy major unmet medical needs.
High blood pressure and related conditions represent one of the world's biggest public health problems, an area of significant unmet medical need and a growing, multibillion - dollar therapeutic market.
«Through this collaboration, we are leveraging our proprietary technologies to identify and develop treatments for a disease with high unmet medical need.
«With PEC - Direct we intend to address a critical unmet medical need for people who are most severely impacted by type 1 diabetes.
Therapeutic benefit has been observed in tumors invaded by T - cells, the so - called inflamed, immunogenic, or «hot» tumors, however, immune approaches for non-inflamed or «cold» tumors remain an important unmet medical need.
New therapies for severe asthma, particularly treatments that reduce exacerbations, remain a significant unmet medical need.
Our mission is to continue to build Silence as a global leader in the field of RNAi therapeutics, where our technology can create a new generation of approaches to address unmet medical need and improve outcomes for patients.
«We are pleased to provide this update regarding our ongoing clinical trial of AST - OPC1 for the treatment of severe cervical spinal cord injuries in patients for whom there are no viable treatment options and a high unmet medical need,» stated Michael Mulroy, President and Chief Executive Officer.
Therapeutic options for patients are limited, which translates into a clear unmet medical need.
Over time, we look forward to studying AST - OPC1 in indications such as these, all of which currently have a high unmet medical need.»
We are a clinical - stage drug discovery and development company advancing innovative therapies to significantly advance the current standard of treatment for serious unmet medical needs.
Dubbed «CIRM 2.0» the plan is characterized as «a radical overhaul» of business as usual in order to achieve CIRM's mission to «accelerate the development of stem cell therapies to patients with unmet medical needs.»
Our new discovery research strategy aims at enhancing our capacity for innovation and at encouraging scientific creativity for diseases with high unmet medical need.
Research at Roche is focusing on diseases with high unmet medical need in the areas of the central nervous system, genitourinary diseases, metabolic diseases, inflammation and bone diseases, oncology and vascular diseases as well as viral diseases.
The CRISPR - Cas technology can be used to screen for druggable targets and to develop gene and cell therapies for unmet medical needs.
Precision medicines have the ability to transform healthcare and treat a myriad of unmet medical needs.
The Caribou technology platform also has the potential to offer new treatments for unmet medical needs within livestock and address the growing global demand for reliable food sources and improved food safety.
Additionally, the Institute's recent alliance with the California Institute for Biomedical Research (Calibr) adds translational research to its capabilities, enabling a new bench - to - bedside model that will accelerate the translation of basic scientific discoveries into critically - needed new medicines for unmet medical needs.
Obesity is recognized as a leading risk factor for a range of serious diseases, including heart disease, stroke and diabetes, and its treatment represents an area of compelling unmet medical need.
For example, Novartis and the University of Pennsylvania's lead candidate (CTL019) for treating a range of hematological malignancies received breakthrough status from the US Food and Drug Administration (FDA) in 2014, permitting access to an expedited drug development pathway for high unmet medical needs (1).
Collaborating with other academic researchers to advance clinical research in areas of high unmet medical need
«We are hoping to address what we see as an unmet medical need,» Lindsley said.
«Invasive fungal infections are a very important unmet medical need,» said University of Illinois and Howard Hughes Medical Institute chemistry professor Martin Burke, who led the study with chemistry professor Chad Rienstra.
«This represents a patient population with the highest unmet medical need among those with diabetes,» said Dick de Zeeuw, MD (University Medical Center Groningen, in the Netherlands).
Determining exactly who has or is at risk for the disease is a critical unmet medical need,» said first author Rohit Loomba, MD, professor of medicine in the Division of Gastroenterology, director of the NAFLD Research Center and a faculty member in the Center for Microbiome Innovation at UC San Diego.
In 2009, MD Anderson opened what remains the only clinic of its kind at a comprehensive cancer center to address the unmet medical needs of its patients with HCV.
To qualify, the project has to meet the following criteria: It must prevent, detect, or treat a disease; treat an area of unmet medical need; reduce health care costs; or contribute toward curing cancer within 30 years.
There hasn't been a new drug developed for Chagas disease for over 30 years so it's the significance of the unmet medical need there that drove our focus to our diseases.
They are the diseases that have the most unmet medical needs.
«It's not the pursuit of the blockbuster; it's simply pursuing unmet medical needs, and not being driven by the market.»
«It's a great unmet medical need,» says Richard Silverman, a chemist at Northwestern University in Evanston, Illinois, who developed OV329.
Genentech's Research department aims to strike a balance between basic biomedical research and translational research aimed at developing therapies for unmet medical needs.
Vikki Hazelwood encourages her biomedical engineering senior project students at Stevens Institute of Technology in Hoboken, New Jersey, to solve an actual unmet medical need.
When an investigational prescription drug shows promise for treating a serious illness or filling an unmet medical need, the Food and Drug Administration (FDA) has special programs available to expedite its clinical testing and approval.
«Stem cells may offer unprecedented opportunities to develop treatments for many diseases with unmet medical needs.
«What is a constant for us is our focus on developing and delivering innovative treatments for unmet medical needs and making sure that our employees have a work environment that inspires a commitment to this mission.»
a b c d e f g h i j k l m n o p q r s t u v w x y z